URI1

URI1 prefoldin like chaperone, the group of Prefoldin subunits|Protein phosphatase 1 regulatory subunits

Basic information

Region (hg38): 19:29923644-30016612

Previous symbols: [ "C19orf2" ]

Links

ENSG00000105176NCBI:8725OMIM:603494HGNC:13236Uniprot:O94763AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the URI1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the URI1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
1
clinvar
7
missense
27
clinvar
27
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 27 6 1

Variants in URI1

This is a list of pathogenic ClinVar variants found in the URI1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-29923724-C-A Abnormality of neuronal migration Benign (Oct 31, 2014)208948
19-29942568-G-C not specified Uncertain significance (Nov 29, 2023)3186971
19-29942581-C-T not specified Uncertain significance (Oct 13, 2023)3186972
19-29942591-C-T not specified Uncertain significance (Sep 22, 2023)3186974
19-29942627-C-G not specified Uncertain significance (Feb 06, 2024)3186978
19-29942632-G-A not specified Uncertain significance (Dec 07, 2021)2408140
19-29942641-C-T not specified Uncertain significance (Dec 04, 2024)3466433
19-29942649-C-G Benign (Jun 01, 2024)2649668
19-29942661-A-G not specified Likely benign (Jun 18, 2024)3331243
19-29985243-A-G not specified Uncertain significance (Jun 24, 2022)2296275
19-29986293-C-T Likely benign (Jul 01, 2023)2649669
19-29986321-G-T not specified Uncertain significance (Apr 09, 2024)3331240
19-29986353-G-C Likely benign (Jul 10, 2018)746812
19-29986383-G-A Likely benign (Jul 31, 2018)748433
19-29986406-A-G not specified Uncertain significance (Jun 22, 2024)3331244
19-30005367-G-A not specified Uncertain significance (Feb 17, 2023)2465473
19-30005436-T-G not specified Uncertain significance (Apr 24, 2024)3331241
19-30005442-A-G not specified Uncertain significance (Nov 27, 2023)3186973
19-30005660-G-T not specified Uncertain significance (Nov 18, 2022)2327803
19-30005664-T-C not specified Uncertain significance (Dec 14, 2023)3186975
19-30005676-G-A not specified Uncertain significance (Feb 13, 2023)2470184
19-30007482-T-C not specified Uncertain significance (Dec 06, 2024)3466442
19-30007496-C-T not specified Uncertain significance (Aug 29, 2024)3466438
19-30007511-A-G not specified Uncertain significance (Dec 28, 2023)3186976
19-30007542-A-G not specified Uncertain significance (Jul 09, 2021)2235906

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
URI1protein_codingprotein_codingENST00000542441 1192061
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00001110.9981256720761257480.000302
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1312932871.020.00001503538
Missense in Polyphen6372.1170.87357948
Synonymous-0.6081131051.080.00000597984
Loss of Function2.671328.40.4580.00000188316

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005650.000555
Ashkenazi Jewish0.0001000.0000992
East Asian0.0003920.000381
Finnish0.0003310.000323
European (Non-Finnish)0.0003580.000343
Middle Eastern0.0003920.000381
South Asian0.0002770.000261
Other0.0003320.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in gene transcription regulation. Acts as a transcriptional repressor in concert with the corepressor UXT to regulate androgen receptor (AR) transcription. May act as a tumor suppressor to repress AR-mediated gene transcription and to inhibit anchorage-independent growth in prostate cancer cells. Required for cell survival in ovarian cancer cells. Together with UXT, associates with chromatin to the NKX3-1 promoter region. Antagonizes transcriptional modulation via hepatitis B virus X protein.;

Recessive Scores

pRec
0.126

Intolerance Scores

loftool
rvis_EVS
-0.51
rvis_percentile_EVS
21.41

Haploinsufficiency Scores

pHI
0.461
hipred
Y
hipred_score
0.586
ghis
0.662

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Uri1
Phenotype

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;regulation of cell growth;regulation of transcription by RNA polymerase II;response to virus;negative regulation of phosphatase activity;negative regulation of phosphoprotein phosphatase activity;cellular response to growth factor stimulus;cellular response to steroid hormone stimulus;negative regulation of intrinsic apoptotic signaling pathway
Cellular component
nucleus;nucleoplasm;cytoplasm;mitochondrion;cytosol;dendrite
Molecular function
RNA polymerase II complex binding;chromatin binding;transcription corepressor activity;protein phosphatase inhibitor activity;protein binding;phosphatase inhibitor activity;phosphoprotein binding